UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13...
Server Application ErrorThe server has encountered an error while loading an application during the processing of your request. Please refer to...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR...
Filed by Regeneration Technologies, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and deemed filed pursuant to Rule 14a-6...
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant...
Rule 424(b)(3) File No. 333-139738 TUTOGEN MEDICAL, INC. SUPPLEMENT TO PROSPECTUS Dated March 29, 2007...
ALACHUA, Fla., Nov. 14 /PRNewswire-FirstCall/ -- Tutogen Medical, Inc. (AMEX:TTG), a leading manufacturer of sterile biological implant products...
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT...
Filed by Regeneration Technologies, Inc. Pursuant to Rule 425 under the Securities Act of 1933 and...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.